181 result(s) found
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
0
Is Now the Time to Buy T-Mobile Stock?
https://www.fool.com/investing/2024/02/26/is-now-the-time-to-buy-t-mobile-stock/?source=iedfolrf0000001
Feb 26, 2024 - The telecom titan delivered strong 2023 performance that looks to continue in 2024.
0
Wall Street Breakfast: Flush With Cash
https://seekingalpha.com/article/4673379-wall-street-breakfast-flush-cash?source=feed_tag_wall_st_breakfast
Feb 26, 2024 - This article discusses bigwigs selling shares and accumulating cash, Samsung's Galaxy Ring, Google disclosing Microsoft's 2018 bid to sell Bing to Apple, and AT&T's $5 outage credit.
0
HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model
https://www.zacks.com/stock/news/2231234/hca-healthcare-hca-drives-efficiency-with-new-outpatient-model?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2231234
Feb 23, 2024 - HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.
0
Want Better Returns? Don?t Ignore These 2 Consumer Discretionary Stocks Set to Beat Earnings
https://www.zacks.com/stock/news/2227782/want-better-returns-don-t-ignore-these-2-consumer-discretionary-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2227782
Feb 19, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
AT&T: FY2024 Guidance Has Been Misunderstood, Buy The Pullback
https://seekingalpha.com/article/4670853-att-fy2024-guidance-misunderstood-buy-pullback-t-stock?source=feed_all_articles
Feb 17, 2024 - AT&T reports a bottom line miss in its FQ4'23 earnings call, with revenue and adj EPS growing YoY. Find out why T stock remains a Buy for income-oriented investors.
0
Iovance gets FDA accelerated approval for advanced melanoma therapy (update)
https://seekingalpha.com/news/4068430-iovance-gets-fda-accelerated-approval-for-advanced-melanoma-therapy?source=feed_sector_healthcare
Feb 16, 2024 - Iovance (IOVA) has received FDA accelerated approval for its T-cell immunotherapy lifileucel, also known as Amtagvi, in the treatment of advanced melanoma. Read more here.
0
2 Bargain Telecom Dividends For A Defensive Retirement, +6% Yields
https://seekingalpha.com/article/4670507-2-bargain-telecom-dividends-for-a-defensive-retirement-plus-6-percent-yields?source=feed
Feb 16, 2024 - AT&T and Verizon continue to report growing free cash flow, while their stock remains undervalued. Learn how these dividends can empower your retirement dreams.
0
Randstad N.V. (RANJF) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4670019-randstad-n-v-ranjf-q4-2023-earnings-call-transcript?source=feed_all_articles
Feb 13, 2024 - Randstad N.V. (OTCPK:RANJF) Q4 2023 Earnings Call Transcript Q4 2023 Earnings Call Transcript February 13, 2024 3:00 AM ETCompany ParticipantsSander van 't...
0
Has Alerus Financial (ALRS) Outpaced Other Finance Stocks This Year?
https://www.zacks.com/stock/news/2225484/has-alerus-financial-alrs-outpaced-other-finance-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2225484
Feb 13, 2024 - Here is how Alerus (ALRS) and T. Rowe Price (TROW) have performed compared to their sector so far this year.
0